ECO 2026
12 - 15 May 2026
Early Responders to Oral Semaglutide 25 mg: A Post Hoc Analysis of the OASIS 4 Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.